Jin Medical International (ZJYL) Cash & Equivalents (2023 - 2025)

Jin Medical International's Cash & Equivalents history runs 3 years deep, the most recent figure standing at $7.5 million for Q3 2025.

• In Q3 2025, Cash & Equivalents changed N/A year-over-year to $7.5 million; the TTM figure through Sep 2025 stood at $7.5 million (changed N/A YoY), while the FY2025 annual figure was $7.5 million, changed N/A from the prior year.
• Cash & Equivalents came in at $7.5 million for Q3 2025 at Jin Medical International, down from $8.1 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $8.1 million in Q1 2025 to a low of $4.8 million in Q1 2023.
• A 3-year average of $6.8 million and a median of $7.2 million in 2024 frame the typical range for Cash & Equivalents.
• Across the five-year window, Cash & Equivalents jumped 44.59% in 2024 and gained 17.41% in 2025, its largest moves.
• Jin Medical International's Cash & Equivalents stood at $4.8 million in 2023, then surged by 44.59% to $6.9 million in 2024, then increased by 7.68% to $7.5 million in 2025.
• According to Business Quant data, Cash & Equivalents over the past three periods registered $7.5 million, $8.1 million, and $6.9 million for Q3 2025, Q1 2025, and Q1 2024 respectively.

Peer Comparison